Valuation: Balaxi Pharmaceuticals Limited

Market Cap 865M 8.98M 7.85M 7.24M 6.68M 12.59M 12.86M 86.59M 34.06M 424M 33.74M 33M 1.46B P/E 2024
-214x
P/E 2025 14.1x
Enterprise Value 992M 10.3M 9M 8.31M 7.66M 14.44M 14.76M 99.32M 39.06M 486M 38.7M 37.85M 1.67B EV / Sales 2024
1.91x
EV / Sales 2025 1.16x
Free-Float
89.66%
Yield 2024 *
-
Yield 2025 -
1 day-0.67%
1 week-2.07%
Current month-1.00%
3 months-10.24%
6 months-5.02%
Current year-11.91%
1 week 23
Extreme 23
24.75
1 month 22.5
Extreme 22.5
24.95
Current year 15.2
Extreme 15.2
29.9
1 year 15.2
Extreme 15.2
52.5
3 years 15.2
Extreme 15.2
151.45
5 years 15.2
Extreme 15.2
151.45
10 years 2.58
Extreme 2.58
216.04
Manager TitleAgeSince
Chief Executive Officer 56 2017-05-03
Director of Finance/CFO - 2021-05-19
Compliance Officer - 2026-03-24
Director TitleAgeSince
Chairman 56 2017-05-03
Director/Board Member 54 -
Director/Board Member 44 2017-05-03
Change 5-day change 1-year change 3-year change Capi.($)
-0.67%-2.07%-51.70%-77.29% 13.57M
+0.01%+4.40%+18.54%+104.90% 98.51B
-0.09%-3.09%+43.22%+145.22% 53.52B
-0.34%+3.90%+4.27%+266.25% 23.53B
-2.52%+2.98%-12.49%-21.65% 8.25B
-5.82%+2.45%-32.81%-32.05% 7.79B
-1.35%+5.02%-6.54%-27.10% 6.99B
+2.44%+0.89%+26.58%+30.99% 6.31B
+0.79%+2.77%-0.39%+25.12% 5.51B
-2.29%+2.00%-4.49%-6.59% 3.76B
Average -0.98%+1.87%-1.58%+40.78% 21.42B
Weighted average by Cap. -0.36%+2.37%+18.60%+112.34%

Financials

2024 2025
Net sales 2.41B 25.06M 21.9M 20.21M 18.62M 35.1M 35.88M 242M 94.99M 1.18B 94.1M 92.03M 4.07B 2.93B 30.38M 26.55M 24.5M 22.58M 42.56M 43.51M 293M 115M 1.43B 114M 112M 4.93B
Net income -23.87M -248K -217K -200K -184K -347K -355K -2.39M -940K -11.69M -931K -910K -40.24M 251M 2.6M 2.28M 2.1M 1.94M 3.65M 3.73M 25.09M 9.87M 123M 9.78M 9.56M 423M
Net Debt -432M -4.48M -3.92M -3.61M -3.33M -6.28M -6.42M -43.21M -16.99M -211M -16.83M -16.46M -728M 127M 1.32M 1.15M 1.07M 982K 1.85M 1.89M 12.73M 5.01M 62.31M 4.96M 4.85M 214M
Logo Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It is engaged in International Wholesale Distribution of Pharmaceuticals. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.
Employees
600
Date Price Change Volume
26-07-17 ₹23.67 -0.67% 49,128
26-07-16 ₹23.83 -1.12% 28,502
26-07-15 ₹24.10 -0.12% 9,948
26-07-14 ₹24.13 +0.37% 28,651
26-07-13 ₹24.04 -0.54% 11,826
  1. Stock Market
  2. Stocks
  3. BALAXI Stock